mdlinx mdlinx

Gastroenterology - Biliary System/Pancreas News & Articles

Available now at MDLinx Gastroenterology: Ranked summaries of the most clinically-relevant GI literature refreshed every 24 hours, as well as MDLinx Gastroenterology exclusive content

  • Our team of dedicated physician medical editors sort, rank and summarize articles in over 2,000 medical journals to bring you the key developments in your uniquely diverse field. In addition to general gastroenterology news, you'll find subspecialty coverage of the biliary system and pancreas, colorectal cancer and polyps, hepatology and liver disease, GI bleeding, GI infectious diseases, gastrointestinal endoscopy, obesity, parenteral and enteral nutrition, diagnostic imaging, and more.
  • MDLinx Gastroenterology exclusive content includes: Monthly highlights of the "can't miss" articles chosen by our physician editor, D. Scott Cunningham, MD, PhD; clinical pearls from The Smartest Internist and Smartest Family Physician daily competitions, a collaboration from the editors of MDLinx and Cleveland Clinic Center for Continuing Education; and pearls from our Pediatrics Physician Review quizzes.

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (13) Full Text Articles (190)
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

341 Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease Journal of Clinical Pathology, April 26, 2013    Review Article

342 Prior Surgery Determines Islet Yield and Insulin Requirement in Patients With Chronic Pancreatitis Transplantation, April 26, 2013    Clinical Article

343 Enhancer of Zeste Homolog 2 Silences MicroRNA-218 in Human Pancreatic Ductal Adenocarcinoma Cells by Inducing Formation of Heterochromatin Gastroenterology, April 26, 2013    Review Article

344 An unusual gallbladder carcinoma with tumor thrombus in the common bile duct Journal of Cancer Research and Therapeutics, April 26, 2013

345 Endoscopic ultrasonography for pancreatic cancer: current and future perspectives Full Text Journal of Gastrointestinal Oncology, April 25, 2013    Clinical Article

346 A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer Full Text Journal of Gastrointestinal Oncology, April 25, 2013    Clinical Article

347 Ultrasound-guided vs endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer diagnosis Full Text World Journal of Gastroenterology, April 25, 2013    Clinical Article

348 Aspartate Aminotransferase-to-Platelet Ratio index (APRi) in infants with biliary atresia: Prognostic value at presentation Journal of Pediatric Surgery, April 25, 2013    Clinical Article

349 Endoscopic snare papillectomy: a possible radical treatment for a subgroup of T1 ampullary adenocarcinomas Endoscopy, April 25, 2013    Review Article

350 In vitro cell tests of pancreatic malignant tumor cells by photothermotherapy based on DMSO porous silicon colloids Lasers in Medical Science, April 25, 2013    Review Article

351 A Patient With Pancreas Divisum, Recurrent Acute Pancreatitis, and Homozygosity for the Cystic Fibrosis Transmembrane Regulator-Associated Protein 5T Allele Clinical Gastroenterology and Hepatology , April 25, 2013

352 Percutaneous hepatic venous stenting for menorrhagia in Budd Chiari Syndrome Liver International, April 25, 2013

353 Gallbladder polyposis in metachromatic leukodystrophy Pediatric Radiology, April 25, 2013

354 Asbestos: a hidden player behind the cholangiocarcinoma increase- Findings from a case-control analysis Cancer Causes and Control, April 24, 2013    Clinical Article

355 Biliary Findings Assist in Predicting Enlargement of Intraductal Papillary Mucinous Neoplasms of the Pancreas Clinical Gastroenterology and Hepatology , April 24, 2013    Clinical Article

356 A prospective, randomized trial of Roux-en-Y reconstruction with isolated pancreatic drainage versus conventional loop reconstruction after pancreaticoduodenectomy Surgery, April 24, 2013    Clinical Article
Exclusive Author Commentary

357 Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: A population based cohort study Hepatology, April 24, 2013    Review Article

358 Biliary Findings and the Neoplastic Potential of Branch Duct Intraductal Papillary Mucinous Neoplasm Clinical Gastroenterology and Hepatology , April 24, 2013    Review Article

359 Laparoscopic excision of a choledochal cyst in 82 consecutive patients Surgical Endoscopy, April 24, 2013    Clinical Article

360 Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer Pancreas, April 24, 2013    Review Article

50 available pages First Previous 18 19 20 21 22 23 24 25 26 27 Next Last

Clinical Pearls in Gastroenterology

Highlights in Gastroenterology

What is the best strategy for CRC screening?

As published in the NEJM, researchers in the COLONPREV study (Spain) have reported that fecal immunochemical testing (FIT) is as effective as colonoscopy in the detection of colorectal cancer (CRC). The study population was 50-69 years of age and comprised of 26,703 subjects who underwent a one-time colonoscopy and 26,599 subjects who underwent FIT every 2 years. The primary outcome measure was CRC deaths at 10 years. Participation in screening was greater in the FIT group than the colonoscopy group (34.2% vs. 24.6%). Detection of CRC was similar between the two groups (0.1%). Advanced and non-advanced adenomas were detected more frequently in the colonoscopy group than the FIT group (1.9% vs. 0.9% [OR=2.3] and 4.2% vs. 0.4% [OR=9.8], respectively).

Read the article summary

PPIs increase risk of Clostridium difficile infection

Based on a meta-analysis involving 30 observational studies and 202,965 patients, proton pump inhibitor therapy has been shown to significantly increase the risk of infection with Clostridium difficile (OR = 2.15).

Read the article summary

Metformin improves survival in patients with DM and CRC

In a single institution study involving 424 patients with DM and CRC, those patients treated with metformin had a 30% improvement in OS compared with patients not treated with metformin. Specifically, the metformin-treated patients had a mean survival of 76.9 months compared to 56.9 months.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Gastro Articles

Last month's top read Top Articles of 2012

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close